MI Cruz, H Cidade, M Pinto - Future Medicinal Chemistry, 2017 - Taylor & Francis
To date, the current therapy for Alzheimer's disease (AD) based on acetylcholinesterase
inhibitors is only symptomatic, being its efficacy limited. Hence, the recent research has …